全身扩散加权MRI与计算机断层扫描对疑似卵巢癌患者术前评估的诊断价值比较
161例疑似卵巢癌患者接受3T全身扩散加权MRI(WB-DWI/MRI)与增强CT检查,比较两者确认卵巢肿块恶性性质与原发来源、FIGO分期及预测不完全切除的能力。WB-DWI/MRI确认恶性性质的准确率显著高于CT(93% vs 82%,p=0.001),FIGO分期正确率更高(82/94,87% vs 33/94,35%),预测不完全切除的敏感度、特异度与准确率均显著优于CT(p<0.001)。
要点
- WB-DWI/MRI确认卵巢肿块恶性性质的准确率显著高于CT(93% vs 82%,p=0.001)。
- WB-DWI/MRI正确识别32例非卵巢来源癌中的26例(81%),CT仅识别10/32(31%)(p<0.001)。
- WB-DWI/MRI预测不完全切除的敏感度94% vs CT 66%,特异度97.7% vs 77.3%,准确率95.7% vs 71.3%(p<0.001)。
核心结论
- 在疑似卵巢癌患者中,WB-DWI/MRI在原发肿瘤特征描述、分期及预测不完全切除方面优于CT。
研究设计与样本
- 161例疑似卵巢癌患者接受3T WB-DWI/MRI与增强CT检查,比较两种方法确认卵巢肿块恶性性质与原发来源、FIGO分期及基于机构可手术性标准预测不完全切除的能力,并评估两名阅片者间的观察者一致性。
主要发现
- WB-DWI/MRI确认卵巢肿块恶性性质的准确率显著高于CT(93% vs 82%,p=0.001)。
- WB-DWI/MRI正确识别32例非卵巢来源癌中的26例(81%),CT识别10/32(31%)(p<0.001)。
- WB-DWI/MRI将更多卵巢癌患者归入正确FIGO分期(82/94,87%),CT为33/94(35%)。
- 预测不完全切除,WB-DWI/MRI敏感度94% vs CT 66%,特异度97.7% vs 77.3%,准确率95.7% vs 71.3%(p<0.001)。
- 预测不完全切除的观察者一致性,WB-DWI/MRI几乎完全一致(κ=0.90),CT中等(κ=0.52)。
关键数值与推荐
- 确认恶性性质准确率:WB-DWI/MRI 93% vs CT 82%(p=0.001)。
- 非卵巢来源癌正确识别:WB-DWI/MRI 26/32(81%)vs CT 10/32(31%)(p<0.001)。
- 正确FIGO分期:WB-DWI/MRI 82/94(87%)vs CT 33/94(35%)。
- 预测不完全切除:敏感度94% vs 66%,特异度97.7% vs 77.3%,准确率95.7% vs 71.3%(p<0.001)。
- 观察者一致性:WB-DWI/MRI κ=0.90,CT κ=0.52。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite excellent per-lesion performance for peritoneal staging, the additional clinical value of diffusion-weighted magnetic resonance imaging (DWI/MRI) compared to computed tomography (CT) remains to be established in ovarian cancer. Our purpose was to evaluate whole body (WB)-DWI/MRI for diagnosis, staging and operability assessment of patients suspected for ovarian cancer compared to CT. METHODS: One hundred and sixty-one patients suspected for ovarian carcinoma underwent 3 T WB-DWI/MRI and contrast-enhanced CT. WB-DWI/MRI and CT were compared for confirmation of the malignant nature and primary origin of the ovarian mass, Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) staging and prediction of incomplete resection using institutional operability criteria. Interobserver agreement between two readers was determined for WB-DWI/MRI and CT. RESULTS: WB-DWI/MRI showed a significantly higher accuracy than CT (93 versus 82%, p = 0.001) to confirm the malignant nature of the ovarian mass and correctly identified 26 of 32 (81%) cancers of non-ovarian origin compared to 10/32 (31%) for CT (p < 0.001). WB-DWI/MRI assigned more ovarian carcinoma patients to the correct FIGO stage (82/94, 87%) compared with CT (33/94, 35%). For prediction of incomplete resection, WB-DWI/MRI showed significantly higher sensitivity (94 versus 66%), specificity (97.7 versus 77.3%) and accuracy (95.7 versus 71.3%) compared to CT (p < 0.001). Interobserver agreement was almost perfect (κ = 0.90) for WB-DWI/MRI and moderate (κ = 0.52) for CT for prediction of incomplete resection. CONCLUSIONS: WB-DWI/MRI was superior to CT for primary tumour characterisation, staging and prediction of incomplete resection in patients suspected for ovarian cancer.
引用
- Michielsen K, Dresen R, Vanslembrouck R, et al. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer. 2017. PMID: 28734146. doi:10.1016/j.ejca.2017.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。